BioVaxys Technology (BioVaxys Technology) Stock Based Compensation : $0.24 Mil (TTM As of Jul. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Stock Based Compensation?

BioVaxys Technology's Stock Based Compensation for the three months ended in Jul. 2023 was $0.03 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jul. 2023 was $0.24 Mil.

BioVaxys Technology Stock Based Compensation Historical Data

The historical data trend for BioVaxys Technology's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Stock Based Compensation Chart

BioVaxys Technology Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Stock Based Compensation

0.27

0.92

0.37

BioVaxys Technology Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Stock Based Compensation	Get a 7-Day Free Trial															0.06	0.12	0.05	0.04	0.03

BioVaxys Technology Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.24 Mil.

BioVaxys Technology Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

BioVaxys Technology (BioVaxys Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

5LB:Germany BIOV:Canada

Address

146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4

Website

https://www.biovaxys.com

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.